Best TWAS P=1.784212e-08 · Best GWAS P=4.963239e-09 conditioned to 1
# | Tissue | Gene | Modality | RNA phenotype | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipose | Cep112 | intron excision ratio | chr10:93731914:93738578 | 0.06 | 0.04 | top1 | 1 | 0.04 | 4.2e-05 | -5.6 | 5.6 | 2.8e-08 | -0.94 | 0.18 | 0.25 | FALSE |
2 | BLA | Axin2 | gene expression | ENSRNOG00000055010 | 0.07 | 0.08 | top1 | 1 | 0.08 | 4.9e-05 | -5.1 | -5.1 | 3.0e-07 | 0.96 | 0.13 | 0.05 | FALSE |
3 | Brain | Prkca | gene expression | ENSRNOG00000003491 | 0.12 | 0.08 | top1 | 1 | 0.08 | 4.3e-08 | -5.6 | -5.6 | 1.8e-08 | 0.95 | 0.25 | 0.74 | TRUE |
4 | Brain | AABR07030647.1 | gene expression | ENSRNOG00000033613 | 0.07 | 0.09 | top1 | 1 | 0.09 | 2.0e-08 | -5.4 | 5.4 | 7.8e-08 | -0.94 | 0.38 | 0.61 | FALSE |
5 | IL | Amz2 | gene expression | ENSRNOG00000000246 | 0.32 | 0.15 | blup | 2767 | 0.17 | 6.0e-05 | 4.8 | 5.1 | 2.9e-07 | -0.91 | 0.33 | 0.65 | FALSE |
6 | IL | Axin2 | gene expression | ENSRNOG00000055010 | 0.32 | 0.17 | blup | 2027 | 0.23 | 3.1e-06 | -5.6 | -5.3 | 9.5e-08 | 0.89 | 0.46 | 0.51 | FALSE |
7 | LHb | Cep112 | gene expression | ENSRNOG00000024557 | 0.35 | 0.25 | top1 | 1 | 0.25 | 1.5e-06 | -5.6 | -5.6 | 2.3e-08 | 0.96 | 0.14 | 0.13 | FALSE |
8 | Liver | Cep112 | isoform ratio | ENSRNOT00000037067 | 0.03 | 0.02 | top1 | 1 | 0.02 | 2.3e-03 | -5.6 | 5.6 | 2.5e-08 | -0.99 | 0.07 | 0.05 | FALSE |
9 | Liver | Apoh | mRNA stability | ENSRNOG00000003566 | 0.27 | 0.26 | enet | 72 | 0.27 | 2.3e-29 | -5.8 | 5.6 | 2.0e-08 | -0.99 | 0.30 | 0.70 | FALSE |
10 | NAcc | Cep112 | alternative TSS | ENSRNOT00000108519 | 0.13 | 0.11 | top1 | 1 | 0.11 | 1.2e-08 | -5.6 | -5.6 | 2.6e-08 | 0.93 | 0.37 | 0.63 | FALSE |
11 | NAcc | Cep112 | gene expression | ENSRNOG00000024557 | 0.06 | 0.07 | top1 | 1 | 0.07 | 1.1e-05 | -5.5 | -5.5 | 4.2e-08 | 0.91 | 0.22 | 0.20 | FALSE |
12 | NAcc | Cep112 | isoform ratio | ENSRNOT00000108519 | 0.14 | 0.11 | blup | 2251 | 0.12 | 2.5e-09 | -5.6 | -5.5 | 3.3e-08 | 0.91 | 0.34 | 0.66 | FALSE |
13 | NAcc | Wipi1 | mRNA stability | ENSRNOG00000003827 | 0.06 | 0.02 | top1 | 1 | 0.02 | 6.2e-03 | -5.5 | 5.5 | 4.1e-08 | -0.83 | 0.09 | 0.12 | FALSE |
14 | PL | Rgs9 | alternative polyA | ENSRNOT00000096063 | 0.04 | 0.02 | top1 | 1 | 0.02 | 9.1e-03 | 5.2 | -5.2 | 2.6e-07 | 0.90 | 0.09 | 0.04 | FALSE |
15 | PL | Cep112 | gene expression | ENSRNOG00000024557 | 0.14 | 0.10 | top1 | 1 | 0.10 | 2.4e-08 | -5.5 | -5.5 | 4.2e-08 | 0.99 | 0.48 | 0.52 | FALSE |
16 | PL | Rgs9 | isoform ratio | ENSRNOT00000005076 | 0.06 | 0.03 | top1 | 1 | 0.03 | 1.4e-03 | -5.1 | 5.1 | 2.8e-07 | -0.90 | 0.13 | 0.08 | FALSE |
17 | PL | Rgs9 | isoform ratio | ENSRNOT00000096063 | 0.04 | 0.02 | top1 | 1 | 0.02 | 6.4e-03 | 5.2 | -5.2 | 2.6e-07 | 0.90 | 0.09 | 0.04 | FALSE |
h2: Heritability estimate for the given transcriptomic model. PP3: Posterior probability of two distinct causal variants. PP4: Posterior probability of a single shared causal variant. joint: Whether the RNA phenotype is in the joint model.